A multicenter randomized prospective study comparing three intravesical therapies, two with bacillus Calmette-Guérin immunotherapy and one with mitomycin C chemotherapy in medium and low risk superficial bladder tumors.

Authors
Category Primary study
JournalEuropean Urology
Year 2000
This article has no abstract
Epistemonikos ID: c689d464bb0de85990da5cf1f0d3cd6a1b556b2b
First added on: Dec 19, 2020